clinical trial · NCT05849961
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
Exactech·—·recruiting·n = 2,946
Hip Arthroplasty, TotalExactech Hip Systems
brief summary
A Post-Market Domestic (US) and International Data Collection to Assess Exactech Hip Systems
started
Oct 13, 2023
primary completion
Jul 31, 2036
completion
Dec 31, 2036
last updated
Jun 18, 2024
detailed description
Patient outcomes data is important for assessing the post-market safety and effectiveness of orthopedic medical devices. The purpose of this study is to collect clinical and patient outcomes and survivorship data for patients who have received or will receive an Exactech Hip System for total hip arthroplasty (THA) prosthesis manufactured or distributed by Exactech Inc (Gainesville, Florida, USA).
official title
TM-2023-017318 Exactech Hip Systems PMCF: A Post-Market Domestic (US) and International Data Collection to Assess Exactech Hip Systems
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol